Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical Trial. | Am J Respir Crit Care Med | 2021 | 34403326 | PubTator, text mining | PubMed |
| Caffeine for the Pharmacological Treatment of Apnea of Prematurity in the NICU: Dose Selection Conundrum, Therapeutic Drug Monitoring and Genetic Factors. | Front Pharmacol | 2021 | 34381359 | PubTator, text mining | PubMed |
| A Rapid Pharmacogenomic Assay to Detect NAT2 Polymorphisms and Guide Isoniazid Dosing for Tuberculosis Treatment. | Am J Respir Crit Care Med | 2021 | 34375564 | PubTator, text mining | PubMed |
| The Green Anti-Cancer Weapon. The Role of Natural Compounds in Bladder Cancer Treatment. | Int J Mol Sci | 2021 | 34360552 | PubTator, text mining | PubMed |
| Metabolic Evidence Rather Than Amounts of Red or Processed Meat as a Risk on Korean Colorectal Cancer. | Metabolites | 2021 | 34357356 | PubTator, text mining | PubMed |
| Predicting the retinal content in omega-3 fatty acids for age-related macular-degeneration. | Clin Transl Med | 2021 | 34323423 | PubTator, text mining | PubMed |
| Weighted Gene Co-expression Network Analysis Identified a Novel Thirteen-Gene Signature Associated With Progression, Prognosis, and Immune Microenvironment of Colon Adenocarcinoma Patients. | Front Genet | 2021 | 34322151 | PubTator, text mining | PubMed |
| Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review. | Neuropsychiatr Dis Treat | 2021 | 34321882 | PubTator, text mining | PubMed |
| Dietary heterocyclic aromatic amine intake and cancer risk: epidemiological evidence from Japanese studies. | Genes Environ | 2021 | 34315542 | PubTator, text mining | PubMed |
| Recurrent Tuberculosis Disease in Singapore. | Open Forum Infect Dis | 2021 | 34307732 | PubTator, text mining | PubMed |
| Key Candidate Genes - VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis. | Cancer Manag Res | 2021 | 34290531 | PubTator, text mining | PubMed |
| Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma. | Ann Transl Med | 2021 | 34277775 | PubTator, text mining | PubMed |
| Case Study 11: Considerations for Enzyme Mapping Experiments-Interaction Between the Aldehyde Oxidase Inhibitor Hydralazine and Glutathione. | Methods Mol Biol | 2021 | 34272718 | PubTator, text mining | PubMed |
| Metabolism and biomarkers of heterocyclic aromatic amines in humans. | Genes Environ | 2021 | 34271992 | PubTator, text mining | PubMed |
| Genetic and Functional Evaluation of the Role of FOXO1 in Antituberculosis Drug-Induced Hepatotoxicity. | Evid Based Complement Alternat Med | 2021 | 34249128 | PubTator, text mining | PubMed |
| Pharmacogenomics of Hypersensitivity to Non-steroidal Anti-inflammatory Drugs. | Front Genet | 2021 | 34249079 | PubTator, text mining | PubMed |
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. | BMC Cancer | 2021 | 34238253 | PubTator, text mining | PubMed |
| Upregulating KTN1 promotes Hepatocellular Carcinoma progression. | J Cancer | 2021 | 34234850 | PubTator, text mining | PubMed |
| Serum iron status and the risk of breast cancer in the European population: a two-sample Mendelian randomisation study. | Genes Nutr | 2021 | 34229617 | PubTator, text mining | PubMed |
| Association of Nucleotide Variants of GRHL3, IRF6, NAT2, SDC2, BCL3, and PVRL1 Genes with Nonsyndromic Cleft Lip With/Without Cleft Palate in Multigenerational Families: A Retrospective Study. | Contemp Clin Dent | 2021 | 34220153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=32